Our Journey
Generic APIs
Complex Chemicals
Contract Research & Manufacturing Services (CRAMS)
In-house Drug Discovery
Development of NCE SUVN-502
Drug Discovery and Services
3 CRAMS projects commercialized
1 more CRAMS project and 1 more specialty chem project commercialized
Demerged into 2 Companies. Commencement of Suven Pharma, a resultant company out of Demerger
Acquires Casper Pharma
Our Milestones
1989
Generic APIs
1992
Complex Chemicals
1995
Contract Research & Manufacturing Services (CRAMS)
2003
In-house Drug Discovery
2005
Initiation of CNS programs with SUVN-502 as a lead molecule
2006
Drug Discovery and Services
2014
3 CRAMS projects commercialized
2019
1 more CRAMS project and 1 more specialty chem project commercialized
2020
Demerged into 2 Companies. Commencement of Suven Pharma, a resultant company out of Demerger
1989
Generic API
1995
Contract Research & Manufacturing Services (CRAMS)
2005
Initiation of CNS programs with SUVN-502 as a lead molecule
2014
3 CRAMS projects commercialized
2020
Demerged into 2 Companies. Commencement of Suven Pharma, a resultant company out of Demerger
1992
Complex Chemicals
2003
In-house Drug Discovery
2006
Drug Discovery and Services
2019
1 more CRAMS project and 1 more specialty chem project commercialized
![Health Canada[268]](https://www.suvenpharm.com/wp-content/uploads/2022/11/Health-Canada268.png)
